Clinical Trial Update: Comparison of Oral 30 % Dextrose and iv Midazolam Sedation During MRI in Neonates [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing oral 30% dextrose to intravenous midazolam for sedation during MRI in neonates; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Trauma

Drugs mentioned

• Dextrose 30% oral solution (Dextrose)
• Midazolam (Midazolam)

Snippet

Sponsor: Baskent University | Conditions: Epilepsy, Trauma | Phase 4 | Status: UNKNOWN